Sector
Chinese firms
Chinese firms are businesses and corporations based in China that operate across various sectors, including technology and finance, and are increasingly engaging in international markets and investments.
Why it’s in the news: They are in the news due to their profitability compared to global peers, a potential AI boom, and significant activity in Hong Kong's IPO market.
Latest on Chinese firms
- Chinese firms trail global peers on profits, but AI power boom offers bright spot: Natixis
- Opinion | How Chinese firms can avoid a Europe-style backlash in Southeast Asia
- How Chinese firms can avoid a Europe-style backlash in Southeast Asia
- 4 mainland Chinese firms jump into cooling Hong Kong IPO market
- Four Chinese firms seek to raise up to $1.83 billion in Hong Kong offerings
- Chinese firms keen on investing in Oman’s International Financial Centre: official
- Chinese firms are now focusing on developing domestic AI hardware and robotics to reduce reliance on foreign technology.
- Chinese firms are catching up with overseas competitors
- Chinese firms have engineered efficiency into their stack from the ground up, while US hyperscalers optimized for scale first and cost second.
- Lower domestic costs and state support enable Chinese firms like Alibaba and Tencent to stretch their AI budgets further than US competitors including OpenAI and Meta.
- Chinese firms grow global market share in 40% of products
- The Chinese AI police tech aimed at physical, psychological and emotional states
Connections
18 entities linked to Chinese firms across the news graph.
Under pressure from (1)
Also connected to (17)
China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?As China and the EU begin crunch trade talks, optimism is in short supplyEU and China to hold two-day talks in Beijing aiming to avert trade warHow US-China RISC-V collaboration is deepening despite chip rivalryChinese firms trail global peers on profits, but AI power boom offers bright spot: NatixisFour Chinese firms seek to raise up to $1.83 billion in Hong Kong offeringsinnovative drugsglobal biomedical marketU.S. carmakersPresident Donald Trumpmainland Chinalaw enforcement technologyglobal market shareoverseas competitorsEfficiencystate supportLower domestic costs